Home
About Us
Company Profile
Management Team
Development History
Honors & Qualifications
Intellectual Property Rights
Technology Platform
Clinical Testing Services
Companion Diagnostic
Dynamic Monitoring
Clinical Study
Pharma Services
YuceNeo
Core Strengths
Central Lab
Biomarker Development and Validation
Development of Neoantigens and Vaccines
Development of Companion Diagnostic
Data Services
Scientific Research
Research Strengths
Research Results
Meta Ladder Institute of Precision Cancer Medicine
Patient Home
Patient Story
News & Information
Company News
Media Reports
Talent Strategy
Staff
Talent Development
Join Us
CH
News&Information
News & Information
Home
>
News & Information
>
Company News
Company News
Media Reports
media reports
Media Reports
2019-12-11
21世纪经济报道:裕策生物CEO高志博| 针对中国人群特色癌种 寻找有价值的治疗药物靶点
MORE
2019-12-05
广东电视台南方财经频道:2019年粤港澳大湾区领军企业500强 尖端科技在领跑
MORE
2019-10-25
科学网:共话肿瘤免疫 助力精准医疗
MORE
2019-05-23
贝壳社:免疫疗法是癌症“终结者”,还是过分狂热?| Biotalk深度
MORE
2019-05-05
测序中国:专访裕策生物产品总监杨琳:关注真实临床需求,肿瘤精准免疫治疗之路终将清晰!
MORE
2019-01-23
医学中文网:2019最值得关注的20家生物科技公司(下)
MORE
First
Previous
1
2
3
4
Next
Last
About Us
Company Profile
Management Team
Development History
Honors & Qualifications
Intellectual Property Rights
Technology Platform
Clinical Testing Services
Companion Diagnostic
Dynamic Monitoring
Clinical Study
Pharma Services
YuceNeo
Core Strengths
Central Lab
Biomarker Development and Validation
Development of Neoantigens and Vaccines
Development of Companion Diagnostic
Data Services
Scientific Research
Research Strengths
Research Results
Meta Ladder Institute of Precision Cancer Medicine
Patient Home
Patient Story
News & Information
Company News
Media Reports
Talent Strategy
Staff
Career Development
Join Us
Copyright©2021
Shenzhen yucebio Technology Co., Ltd. all rights reserved
Yueicp no.16128839
Technical support: muxing planning
Top